Skip to content

Clinical trials

Phase 2 Weight Gain trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Phase: Phase 2 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20073
20083
20091
20101
20121
20141
20171
20191
20201
20222
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corcept Therapeutics2
The University of Texas Health Science Center, Houston2
University of North Carolina, Chapel Hill2
AHS Cancer Control Alberta1
Aardvark Therapeutics, Inc.1
Children's Hospital Medical Center, Cincinnati1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Gabriella Milos1
Guilan University of Medical Sciences1
National Institute of Allergy and Infectious Diseases (NIAID)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain20
Obesity10
Schizophrenia4
Mental Disorders2
Anorexia Nervosa1
Bipolar Disorder1
Body-Weight Trajectory1
Bulimia1
Diabetes Mellitus1
Hyperglycemia1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.